Cargando…
GATA3-dependent epigenetic upregulation of CCL21 is involved in the development of neuropathic pain induced by bortezomib
The incidence of bortezomib-induced neuropathic pain hampers the progress of therapy for neoplasia and also negatively affects the quality of life of patients. However, the molecular mechanism underlying bortezomib-induced neuropathic pain remains unknown. In this study, we found that the applicatio...
Autores principales: | Zheng, Yaochao, Sun, Yang, Yang, Yanling, Zhang, Subo, Xu, Ting, Xin, Wenjun, Wu, Shaoling, Zhang, Xiangzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630071/ https://www.ncbi.nlm.nih.gov/pubmed/31257992 http://dx.doi.org/10.1177/1744806919863292 |
Ejemplares similares
-
Reduction of SIRT1 epigenetically upregulates NALP1 expression and contributes to neuropathic pain induced by chemotherapeutic drug bortezomib
por: Chen, Kun, et al.
Publicado: (2018) -
Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain
por: Biber, Knut, et al.
Publicado: (2014) -
NFATc2-dependent epigenetic upregulation of CXCL14 is involved in the development of neuropathic pain induced by paclitaxel
por: Liu, Meng, et al.
Publicado: (2020) -
Epigenetic modifications in neuropathic pain
por: Luo, Danzhi, et al.
Publicado: (2021) -
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
por: Stockstill, Katherine, et al.
Publicado: (2018)